Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9815216rdf:typepubmed:Citationlld:pubmed
pubmed-article:9815216lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0009450lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0221423lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C1550587lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C2745888lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C2346689lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C1550025lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9815216lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9815216pubmed:issue6lld:pubmed
pubmed-article:9815216pubmed:dateCreated1999-1-7lld:pubmed
pubmed-article:9815216pubmed:abstractTextThe effect of acute coinfections on plasma human immunodeficiency virus (HIV) load and immune activation markers was evaluated. Thirty-two HIV-infected persons were prospectively enrolled; 18 had pre-illness, acute, and follow-up specimens. Plasma HIV RNA levels were determined by reverse transcriptase-polymerase chain reaction, and serum levels of activation markers, including tumor necrosis factor (TNF)-alpha, soluble (s) TNF receptors (R)-I and -II, interleukin (IL)-2, IL-6, IL-10, sIL-2R, sCD4, and sCD8, were assessed by commercial ELISAs. Median plasma HIV load increased 7. 8-fold during illness (P=.001) and decreased 1.5-fold (P=.01) during convalescence (median, 15 days). Significant virus load reductions were limited to subjects with clinical recovery. By regression analysis, changes in plasma HIV RNA were significantly associated with changes in sTNFR-I, sTNFR-II, and sIL-2R. Increased HIV replication during acute coinfections is associated with in vivo immune activation, which underscores the need to prevent and promptly treat intercurrent illnesses.lld:pubmed
pubmed-article:9815216pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:languageenglld:pubmed
pubmed-article:9815216pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9815216pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9815216pubmed:statusMEDLINElld:pubmed
pubmed-article:9815216pubmed:monthDeclld:pubmed
pubmed-article:9815216pubmed:issn0022-1899lld:pubmed
pubmed-article:9815216pubmed:authorpubmed-author:MooreR DRDlld:pubmed
pubmed-article:9815216pubmed:authorpubmed-author:QuinnT CTClld:pubmed
pubmed-article:9815216pubmed:authorpubmed-author:MargolickJ...lld:pubmed
pubmed-article:9815216pubmed:authorpubmed-author:ChaissonR ERElld:pubmed
pubmed-article:9815216pubmed:authorpubmed-author:KarpC LCLlld:pubmed
pubmed-article:9815216pubmed:authorpubmed-author:SulkowskiM...lld:pubmed
pubmed-article:9815216pubmed:issnTypePrintlld:pubmed
pubmed-article:9815216pubmed:volume178lld:pubmed
pubmed-article:9815216pubmed:ownerNLMlld:pubmed
pubmed-article:9815216pubmed:authorsCompleteYlld:pubmed
pubmed-article:9815216pubmed:pagination1642-8lld:pubmed
pubmed-article:9815216pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:meshHeadingpubmed-meshheading:9815216-...lld:pubmed
pubmed-article:9815216pubmed:year1998lld:pubmed
pubmed-article:9815216pubmed:articleTitleThe effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.lld:pubmed
pubmed-article:9815216pubmed:affiliationDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.lld:pubmed
pubmed-article:9815216pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9815216pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9815216lld:pubmed